Kevin Schwartz, CEO and managing partner of the firm, cited the company's robust portfolio and long-term strategic potential as primary drivers for the intended purchases. Having backed the business since August 2021, the firm maintains that its thesis regarding the brand's fundamental health remains intact despite market fluctuations.

Any future acquisition of Suja Life common stock remains at the firm's discretion, contingent upon prevailing market conditions and regulatory requirements. The firm holds no obligation to complete specific purchase volumes and retains the right to suspend or discontinue buying activity at any time without prior notice.